Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2005-05-03
2005-05-03
Devi, S. (Department: 1645)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007900, C435S961000, C435S962000, C436S177000, C436S174000, C436S536000, C436S825000, C436S501000
Reexamination Certificate
active
06887669
ABSTRACT:
The present invention relates to a method for releasing a ligand from a complex of the ligand with an endogenous protein using a releasing agent.
REFERENCES:
patent: 3817837 (1974-06-01), Rubenstein et al.
patent: 3996345 (1976-12-01), Ullman et al.
patent: 4052504 (1977-10-01), Hertl et al.
patent: 4110076 (1978-08-01), Margherita
patent: 4233402 (1980-11-01), Maggio et al.
patent: 4275149 (1981-06-01), Litman et al.
patent: 4318980 (1982-03-01), Boguslaski et al.
patent: 4332786 (1982-06-01), Cabelli et al.
patent: 4451571 (1984-05-01), Allen
patent: 4454232 (1984-06-01), Breglio et al.
patent: 4486530 (1984-12-01), David et al.
patent: 4559291 (1985-12-01), Neumann et al.
patent: 4798804 (1989-01-01), Khanna et al.
patent: 4857453 (1989-08-01), Ullman et al.
patent: 4868104 (1989-09-01), Kurn et al.
patent: 4959303 (1990-09-01), Milburn et al.
patent: 5089390 (1992-02-01), Davalian et al.
patent: 5185243 (1993-02-01), Ullman et al.
patent: 6159698 (2000-12-01), Staples et al.
patent: 6171801 (2001-01-01), Staples et al.
patent: 2014233 (1990-10-01), None
patent: 0 100 543 (1984-02-01), None
patent: 0 155 104 (1985-09-01), None
patent: 0 165 699 (1985-12-01), None
patent: 0 218 309 (1987-04-01), None
patent: 0 392 332 (1990-10-01), None
patent: WO 8300147 (1983-01-01), None
patent: WO9602004 (1996-01-01), None
Tabachnick et al. Arch. Biochem. Biophys. 136: 467-479, 1970.*
Bowmer et al. J. Pharm. Pharmacol. 37: 812-815, 1985.*
Shaw et al. Ther. Drug Monitor. 17: 685-689, 1995.*
Nishijo et al. Chem. Pharm. Bull. 33: 2648-2653, 1985.*
Lucanska et al. Zb. Celostatnej Konf. Term. Anal. 8th: 255-258, 1979, abstract.*
Pethe et al. Indian J. Chem. 15A: 998-1001, 1977.*
Basak et al. Asian J. Chem. 5: 316-318, 1993.*
Strinna Erre et al. Polyhedron 6: 1869-1874, 1987.*
Broughton and Strong, Clin. Chem. 22:726-732 (1976).
Butler,J. Immunol Meth. 7:1-24(1975).
Carey, “Organic Chemistry,” McGraw Hill Inc., New York, New York, First edition, 1987, pp. 994-995 and 609.
Cuatrecasas,J. Biol. Chem.,245:3059 (1970).
Epinette, et al.,Journal of the American Academy of Dermatology17(6):1962-71 (1987).
Galfre, et al., (1981) Preparation of Monoclonal Antibodies: Strategies and Procedures,Methods Enzymol,73:3-46.
Grabarek, et al., (1990) Zero-length Crosslinking Procedure With The Use of Active Esters,Anal. Biochem.185: 131-135.
Heathcock, et al., “Introduction to Organic Chemistry,” MacMillan Publishing Company, New York, New York, Third edition, 1985, pp. 814 and 493.
Kohler and Milstein,Nature256:495-497, 1975.
Langman, et al.,Therapeutic Drug Monitoring(1994) 16:602-607.
Lee, et al.,Pharmaceutical Research 7(2):161-166 (1990).
Lymphocyte Hybridomas, ed. Melchers, et al. Springer-Verlag (New York 1978).
Nature 266:495 (1977).
Nelson, et al.Journal of Medicinal Chemistry33 (2) :833-838 (1990).
Nerli, et al.Arch Int Physiol Biochim Biophys(1994) 102 (1):5-8.
Playfair, et al.Br. Med. Bull,30:24-31 (1974).
Science 208:693 (1980).
Seth et al.,Clin Chem.(1975) 21(10): 1406-1413.
Shaw, et al.Therapeutic Drug Monitoring,(1995) 17:690-699.
Wu,Perspective in Drug Discovery and Design,(1994) 2:185-204.
Yalow, et al.,J. Clin. Invest,39:1157 (1960).
Tsina, I., et al., High-performance liquid chromatographic method for the determination of mycophenolate mofetil in human plasma,Journal of Chromatography B,681 (1996) 347-353.
Haley, C.J., et al., Analytical Performance of an Emit Assay for Mycophenolic Acid in Plasma,Clinical Chemistry,vol. 43, No. 6, 1997, Abstract No. 474.
Allison A., et al., Mechanisms of Action of Mycophenolic Acid,Annals of the New York Academy of Sciences,vol. 696, pp. 63-87, 1993.
Holt, D.W., et al., Monitoring New Immunosuppressive Agents, Are the Methods Adequate?,Drug Metabolism and Drug Interactions,vol. 14, No. 1, 1992.
Yatscoff, R.W., et al, Pharmacodynamic Monitoring of Immunosuppressive Drugs,Transplantation Proceedings,vol. 28, No. 6 (Dec.) 1996: pp 3013-3015.
Loralie J. Langman et al., “Blood Distribution of Mycophenolic Acid,”therapeutic Drug Monitoring:A Journal Devoted To Therapeutic Drug Monitoring and Clinical Drug Toxicology, vol. 16, No. 6, Dec. 1994, pp. 602-607.
Irene Nowak et al., Mycophenolic Acid Binding to Human Serum Albumin: Characterization and Relation to Pharmacodynamics, “Clinical Chemistry”, vol. 41, No. 7, 1995, pp. 1011-1017.
Haley Carolyn J.
Parrish Richard F.
Staples Mark A.
Zmolek Wesley W.
Dade Behring Marburg GmbH
Devi S.
Lowen Cara
Ruszala Lois K.
Tymeson Cynthia G.
LandOfFree
Reagents for assays for ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Reagents for assays for ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reagents for assays for ligands will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3433909